Biobanks in the Era of Digital Medicine

Digitalization is currently permeating virtually all sectors of modern societies, including biomedical research and medical care. At the same time, biobanks engaged in the long‐term storage of biological samples that are fit for purpose have become key drivers in both fields. The present article hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Gunnar, Wolf, Andreas, Krawczak, Michael, Lieb, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Discovery & Development
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946992/
https://www.ncbi.nlm.nih.gov/pubmed/29285753
http://dx.doi.org/10.1002/cpt.968
_version_ 1783322282090823680
author Jacobs, Gunnar
Wolf, Andreas
Krawczak, Michael
Lieb, Wolfgang
author_facet Jacobs, Gunnar
Wolf, Andreas
Krawczak, Michael
Lieb, Wolfgang
author_sort Jacobs, Gunnar
collection PubMed
description Digitalization is currently permeating virtually all sectors of modern societies, including biomedical research and medical care. At the same time, biobanks engaged in the long‐term storage of biological samples that are fit for purpose have become key drivers in both fields. The present article highlights some of the challenges and opportunities that biobanking is facing in the current proverbial “era of digitalization.”
format Online
Article
Text
id pubmed-5946992
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59469922018-05-17 Biobanks in the Era of Digital Medicine Jacobs, Gunnar Wolf, Andreas Krawczak, Michael Lieb, Wolfgang Clin Pharmacol Ther Discovery & Development Digitalization is currently permeating virtually all sectors of modern societies, including biomedical research and medical care. At the same time, biobanks engaged in the long‐term storage of biological samples that are fit for purpose have become key drivers in both fields. The present article highlights some of the challenges and opportunities that biobanking is facing in the current proverbial “era of digitalization.” John Wiley and Sons Inc. 2017-12-29 2018-05 /pmc/articles/PMC5946992/ /pubmed/29285753 http://dx.doi.org/10.1002/cpt.968 Text en © 2017 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Discovery & Development
Jacobs, Gunnar
Wolf, Andreas
Krawczak, Michael
Lieb, Wolfgang
Biobanks in the Era of Digital Medicine
title Biobanks in the Era of Digital Medicine
title_full Biobanks in the Era of Digital Medicine
title_fullStr Biobanks in the Era of Digital Medicine
title_full_unstemmed Biobanks in the Era of Digital Medicine
title_short Biobanks in the Era of Digital Medicine
title_sort biobanks in the era of digital medicine
topic Discovery & Development
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946992/
https://www.ncbi.nlm.nih.gov/pubmed/29285753
http://dx.doi.org/10.1002/cpt.968
work_keys_str_mv AT jacobsgunnar biobanksintheeraofdigitalmedicine
AT wolfandreas biobanksintheeraofdigitalmedicine
AT krawczakmichael biobanksintheeraofdigitalmedicine
AT liebwolfgang biobanksintheeraofdigitalmedicine

Ejemplares similares